Source:
https://www.biorxiv.org/content/10.1101/2021.10.24.465626v1
https://www.drugs.com/clinical_trials/gilead-merck-initiate-phase-2-study-evaluating-oral-weekly-combination-regimen-investigational-19721.html#:~:text=Lenacapavir%20is%20Gilead%E2%80%99s%20potential%20first-in-class%2C%20investigational%20long-acting%20HIV-1,for%20the%20treatment%20and%20prevention%20of%20HIV-1%20infection


Dr. Paul Cottrell
Website
http://www.the-studio-reykjavik.com

Patreon
https://www.patreon.com/paulcottrell

Paul Cottrell (First Channel)
https://www.youtube.com/channel/UCZyk2NYx6wGnpoJ7ApTxWKg

Dr Paul Cottrell (Second Channel)
https://www.youtube.com/channel/UCwnfLGgT1x0bvjvIO_8rKzg

Dr. Paul Cottrell (Third Channel)
https://www.youtube.com/channel/UC2uFLRODwiraqAY8lb5RSfg

Dr. Paul Cottrell (Fourth Channel)
https://www.youtube.com/channel/UCV82lcrj_nknTodMz0UYqig

Brighteon Channel
https://www.brighteon.com/channels/paulcottrell

Rumble (DrPaulCottrell)
https://rumble.com/c/c-728277

Podcast
http://paulcottrell.podomatic.com/

Books:
https://www.amazon.com/Paul-Cottrell/e/B07DSPV44D?ref=sr_ntt_srch_lnk_2&;qid=1609172968&sr=8-2

Twitter
https://www.twitter.com/dr_cottrell

Facebook
https://www.facebook.com/paul.cottrell.92798

Freedom Restoration Foundation
https://www.facebook.com/groups/1017608155367475/

* Dr. Paul Cottrell does not represent Harvard University in any official capacity. His comments are his alone.

** Please contact your healthcare professional on your particular healthcare questions and concerns.